The diabetes care devices market was worth over $19bn in 2020 and is expected to grow to $25.4bn by 2025 with a CAGR of 6.5%, driven...
Prior to the COVID-19 pandemic, the diagnosed prevalence of type 1 diabetes (T1D) was predicted to grow annually by 0.93% in the US, and the diagnosed...